A phase 2 clinical trial of pemetrexed plus gemcitabine as front-line chemotherapy for patients with malignant pleural mesothelioma (MPM).

被引：0
|
作者：
Janne, PA
Obasaju, C
Simon, G
Taub, R
Kelly, K
Fidias, P
Bloss, LP
Kindler, HL
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Lilly Oncol, Indianapolis, IN USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ Nacl Colombia, New York, NY USA
[5] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[6] Univ Chicago, Ctr Med, Chicago, IL USA
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7053
引用
收藏
页码：629S / 629S
页数：1
相关论文
共 50 条
  • [1] An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial
    Janne, PA
    Simon, GR
    Langer, CJ
    Taub, RN
    Dowlati, A
    Fidias, P
    Bloss, LP
    Ye, Z
    Obasaju, C
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [2] An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial
    Janne, P
    Simon, G
    Langer, C
    Taub, R
    Dowlati, A
    Fidias, P
    Bloss, L
    Ye, Z
    Obasaju, C
    Kindler, H
    LUNG CANCER, 2005, 49 : S282 - S282
  • [3] A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)
    Zucali, P. A.
    Ceresoli, G. L.
    Favaretto, A. G.
    Cortinovis, D.
    Grossi, F.
    Marangolo, M.
    Del Conte, G.
    Ceribelli, A.
    Bearz, A.
    Parra, H. Soto
    Santoro, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 28 - 28
  • [4] A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)
    Parra, HS
    Zucali, R
    Favaretto, A
    Grossi, F
    Fusi, A
    Marangolo, M
    Del Conte, G
    Ceribelli, A
    Bearz, A
    Ceresoli, G
    LUNG CANCER, 2005, 49 : S229 - S229
  • [5] A phase 2 clinical trial of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM).
    Simon, GR
    Janne, PA
    Langer, CJ
    Verschraegen, CF
    Dowlati, A
    Gadgeel, SM
    Kelly, K
    Taylor, L
    Obasaju, CK
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 679S - 679S
  • [6] Antimesothelin vaccine CRS-207 plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM).
    Hassan, Raffit
    Alley, Evan W.
    Kindler, Hedy Lee
    Antonia, Scott Joseph
    Jahan, Thierry Marie
    Jacobs-Small, Mona
    Hull, Jennifer
    McDougall, Katherine
    Lemmens, Ed
    Murphy, Aimee
    Grous, John J.
    Dubensky, Thomas
    Brockstedt, Dirk G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] A finalized phase II report of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM).
    Simon, G. R.
    Janne, P. A.
    Langer, C.
    Clarie, V.
    Dowlati, A.
    Gadgeel, S. M.
    Kelly, K.
    Ye, Z.
    Obasaju, C. K.
    Hood, K. E.
    Kindler, H. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 91S - 91S
  • [8] Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma
    Janne, Pasi A.
    Simon, George R.
    Langer, Corey J.
    Taub, Robert N.
    Dowlati, Afshin
    Fidias, Panos
    Monberg, Matthew
    Obasaju, Coleman
    Kindler, Hedy
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1465 - 1471
  • [9] A phase II study of pernetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelimma (MPM).
    Ceresoli, GL
    Zucali, PA
    Favaretto, A
    Marangolo, M
    Del Conte, G
    Grossi, F
    Ceribelli, A
    Bidoli, P
    Bearz, A
    Santoro, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 663S - 663S
  • [10] Treatment with gemcitabine and vinorelbine (GEMVIN) as second-line chemotherapy in pemetrexed-pretreated patients with malignant pleural mesothelioma (MPM)
    Garassino, Isabella
    Ceresoli, Giovanni L.
    De Vincenzo, Fabio
    Zucali, Paolo A.
    Cavina, Raffaele
    Campagnoli, Elisabetta
    Salamina, Silvia
    Parra, Hector J. Soto
    Santoro, Armando
    ANNALS OF ONCOLOGY, 2006, 17 : 231 - 231
12345